veklury pulver für konzentrat zur herstellung einer infusionslösung
gilead sciences switzerland sàrl - remdesivirum - pulver für konzentrat zur herstellung einer infusionslösung - praeparatio cryodesiccata: remdesivirum 100 mg, sulfobutylbetadexum natricum 3.146 g, acidum hydrochloridum, natrii hydroxidum, pro vitro corresp. natrium 211.8 mg. - corona virus disease 2019 (covid-19) - synthetika
veklury solution
gilead sciences canada inc - remdésivir - solution - 100mg - remdésivir 100mg - nucleosides and nucleotides
veklury poudre pour solution
gilead sciences canada inc - remdésivir - poudre pour solution - 100mg - remdésivir 100mg - nucleosides and nucleotides
veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.